One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Effect of Timing by Endometrial Receptivity Testing vs Standard Timing of Frozen Embryo Transfer on Live Birth in Patients Undergoing In Vitro FertilizationA Randomized Clinical Trial
Nicole Doyle, MD, PhD1; Samad Jahandideh, PhD1; Micah J. Hill, DO2; Eric A. Widra, MD1; Michael Levy, MD1; Kate Devine, MD1
doi : 10.1001/jama.2022.20438
December 6, 2022, Vol 328, No. 21, Pages 2085-2170
Importance Endometrial receptivity testing is purported to improve live birth following frozen embryo transfer by identifying the optimal embryo transfer time for an individual patient; however, data are conflicting.
Association of Medicare Advantage vs Traditional Medicare With 30-Day Mortality Among Patients With Acute Myocardial Infarction
Bruce E. Landon, MD, MBA1,2; Timothy S. Anderson, MD, MA2; Vilsa E. Curto, PhD3; Peter Cram, MD, MBA4; Christina Fu, MS1; Gabe Weinreb, BA1; Alan M. Zaslavsky, PhD1; John Z. Ayanian, MD, MPP5,6,7,8
doi : 10.1001/jama.2022.20982
Importance Medicare Advantage health plans covered 37% of beneficiaries in 2018, and coverage increased to 48% in 2022. Whether Medicare Advantage plans provide similar care for patients presenting with specific clinical conditions is unknown.
Association Between Individual Primary Care Physician Merit-based Incentive Payment System Score and Measures of Process and Patient Outcomes
Amelia M. Bond, PhD1; William L. Schpero, PhD1; Lawrence P. Casalino, MD, PhD1; Manyao Zhang, MS1; Dhruv Khullar, MD, MPP1,2
doi : 10.1001/jama.2022.20619
Importance The Medicare Merit-based Incentive Payment System (MIPS) influences reimbursement for hundreds of thousands of US physicians, but little is known about whether program performance accurately captures the quality of care they provide.
US Trends in Drug Overdose Mortality Among Pregnant and Postpartum Persons, 2017-2020
Emilie Bruzelius, MPH1; Silvia S. Martins, MD, PHD1
doi : 10.1001/jama.2022.17045
Premiums and Out-of-Pocket Spending for Long-acting Insulins Under the Medicare Part D Senior Savings Model
Khrysta Baig, MSPH1; Stacie B. Dusetzina, PhD1
doi : 10.1001/jama.2022.17232
Medicaid’s Moment for Protecting and Promoting Women’s Health
Mohammad Hussain Dar, MD1; Charissa Fotinos, MD, MS2; Christopher R. Cogle, MD3
doi : 10.1001/jama.2022.21048
Medicare 2.0—A Vision for the Future of America’s Health Insurance Plan
Micah Johnson, MD1; Donald M. Berwick, MD, MPP2
doi : 10.1001/jama.2022.22092
An Innovation Surcharge to Fund the Repurposing of Generic Drugs
James C. Robinson, PhD1
doi : 10.1001/jama.2022.21250
How Much of an “Advantage� Is Medicare Advantage?
David J. Meyers, PhD, MPH1; Andrew M. Ryan, PhD1; Amal N. Trivedi, MD, MPH1
doi : 10.1001/jama.2022.21892
Pay for PerformanceWhen Slogans Overtake Science in Health Policy
J. Michael McWilliams, MD, PhD1,2
doi : 10.1001/jama.2022.20945
Progress and Challenges in Bacterial Meningitis
Rodrigo Hasbun, MD, MPH1
doi : 10.1001/jama.2022.20521
Importance Bacterial meningitis is a worldwide health problem, with incidence rates ranging from approximately 0.9 per 100 000 individuals per year in high-income countries to 80 per 100 000 individuals per year in low-income countries. In low-income countries, bacterial meningitis has a mortality rate of up to 54%. Up to 24% of those who survive develop chronic neurological sequelae, such as hearing loss or focal neurological deficits.
Adjustment for Baseline Characteristics in Randomized Clinical Trials
Mathias J. Holmberg, MD, MPH, PhD1,2; Lars W. Andersen, MD, MPH, PhD, DMSc2,3,4
doi : 10.1001/jama.2022.21506
Peritoneal Fluid Analysis in Peritoneal Dialysis–Associated Peritonitis
Jeffrey Perl, MD, SM1; Ziv Harel, MD, MSc1; Sharon J. Nessim, MD, MSc2
doi : 10.1001/jama.2022.21289
Highlights From Infectious Disease Week 2022—COVID-19, HIV, Monkeypox, and Polio
Melissa Suran, PhD, MSJ
doi : 10.1001/jama.2022.17754
How Immune-Evasive Omicron Offspring and a Lack of Mitigation Measures Could Shape a COVID-19 Winter Wave
Rita Rubin, MA
doi : 10.1001/jama.2022.17758
“This Is Our COVID�—What Physicians Need to Know About the Pediatric RSV Surge
Jennifer Abbasi
doi : 10.1001/jama.2022.21638
Losartan Decreases Incidence of Epilepsy in Arterial Hypertension
Anita Slomski
doi : 10.1001/jama.2022.20025
Short Life Expectancy No Deterrent to Cancer Screening for Some Physicians
Anita Slomski
doi : 10.1001/jama.2022.20024
Long-term Intensive Blood Pressure Control Hard to Maintain
Anita Slomski
doi : 10.1001/jama.2022.20026
Group Recommends Clinical Instruments to Measure Atopic Eczema Burden
Anita Slomski
doi : 10.1001/jama.2022.20027
FDA Approves Artificial Intelligence Device for Guiding Regional Anesthesia
Howard D. Larkin
doi : 10.1001/jama.2022.20029
Cooling Device to Prevent Chemotherapy Oral Mucositis Gains Authorization
Howard D. Larkin
doi : 10.1001/jama.2022.20030
Final Results for Study of Transvaginal Mesh for Pelvic Organ Prolapse
Howard D. Larkin
doi : 10.1001/jama.2022.22134
SARS-CoV-2 Reduction in Shared Indoor Air
Devabhaktuni Srikrishna, MS1; Abraar Karan, MD, MPH2; Ranu S. Dhillon, MD3
doi : 10.1001/jama.2022.18028
SARS-CoV-2 Reduction in Shared Indoor Air
P. Jacob Bueno de Mesquita, PhD1; Rosemary Sokas, MD, MOH2
doi : 10.1001/jama.2022.18025
SARS-CoV-2 Reduction in Shared Indoor Air—Reply
Deborah Dowell, MD, MPH1; William G. Lindsley, PhD1; John T. Brooks, MD1
doi : 10.1001/jama.2022.18031
Association Between COVID-19 Booster Vaccination and Omicron Infection in a Cohort of Players and Staff in the National Basketball Association
Arun Manmadhan, MD1; Tania Ahuja, PharmD2
doi : 10.1001/jama.2022.18034
Association Between COVID-19 Booster Vaccination and Omicron Infection in a Cohort of Players and Staff in the National Basketball Association—Reply
Christina D. Mack, PhD, MSPH1; Deverick J. Anderson, MD2; John DiFiori, MD3
doi : 10.1001/jama.2022.18036
